IPD.AX · IMPEDIMED LIMITED
Australia · RS rating 45 · As of 2026-10-14
| Price | 0.01 AUD |
|---|---|
| 1-day change | +16.7% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 98 / 83 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 14 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +86.0% |
| Market cap (USD) | $15.3M |